中文 | English
Return
Total: 71 , 1/8
Show Home Prev Next End page: GO
Author:(Meng-jie QIU)

1.Trends in incidence and mortality of lung cancer in Huangpu District from 2002 to 2019

QIU Fengqian ; ZHAO Junfeng ; CHEN Weihua ; DU Juan ; JI Yunfang ; GAO Shuna ; MENG Jie ; HE Lihua ; CHEN Bo ; ZHANG Yan

Journal of Preventive Medicine 2025;37(2):143-147

2.The link between endoplasmic reticulum stress and glial cell activation-mediated neuroinflammation in epilepsy

Sheng-Jie XU ; Jia-Qiu XI ; Xiao-Wen YU ; Xiao-Fan MENG ; Zhong-Lin WANG

Medical Journal of Chinese People's Liberation Army 2024;49(4):475-481

3.Exploration of potential biomarkers and therapeutic targets for trauma-related acute kidney injury

Peng QI ; Meng-Jie HUANG ; Wei WU ; Xue-Wen REN ; Yong-Zhi ZHAI ; Chen QIU ; Hai-Yan ZHU

Chinese Journal of Traumatology 2024;27(2):97-106

4.Study on the toxicity characteristics of a clinical bloodstream isolate of Salmonella Telelkebir

En-Hui ZHENG ; Yu-Feng QIU ; Jian-Hui CHEN ; Ya-Dong GAO ; Meng-Ying HUANG ; Qu-Wen LI ; Jie LIN ; Shun-Tai WENG

Chinese Journal of Zoonoses 2024;40(1):31-39

5.Research on the robustness of Ethos cervical cancer online fully automatic generation of adaptive plans

Bo YANG ; Zhiqun WANG ; Xiangyin MENG ; Yongguang LIANG ; Tingtian PANG ; Xingliu WANG ; Xiaoshen WANG ; Hongying LUO ; Jiawei CHEN ; Fuqiang CHEN ; Zongkai ZHOU ; Zhen ZHANG ; Jie QIU

Chinese Journal of Radiation Oncology 2024;33(2):145-151

6.Performance evaluation of Ethos intelligent optimization engine in automatic plan generation

Zhiqun WANG ; Bo YANG ; Xiangyin MENG ; Yongguang LIANG ; Tingtian PANG ; Xingliu WANG ; Xiaoshen WANG ; Hongying LUO ; Jiawei CHEN ; Fuqiang CHEN ; Zongkai ZHOU ; Zhen ZHANG ; Jie QIU

Chinese Journal of Radiation Oncology 2024;33(4):339-345

7.Preliminary study on the mechanism of halofuginone inhibiting the activity of HepG2 cells

Meng-yang CHEN ; Rui-ping HUAI ; Dan-ni YANG ; Li-jie LEI ; Qiu-lin PU ; Li-li XIONG

Acta Pharmaceutica Sinica 2024;59(2):368-373

8.Clinical observation of camrelizumab combined with pemetrexed and nedaplatin in the treatment of EGFR/ALK wild-type advanced non-squamous non-small cell lung cancer

Fengyan TAN ; Yiding TANG ; Long MENG ; Jie SONG ; Feng QIU ; Rui LONG

China Pharmacy 2024;35(16):2013-2017

9.Exploring the mechanism of IgA vasculitis pathogenesis through the interaction of thrombin and inflammatory factors using urinary proteomics

Meng-Meng LIU ; Gai-Ling HOU ; Xiao-Qing YANG ; Qiu-Shuang ZHANG ; Xiao-Feng MEI ; Ying DING ; Lan SONG ; Yan-Jie HUANG

Chinese Journal of Contemporary Pediatrics 2024;26(7):683-689

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 71 , 1/8 Show Home Prev Next End page: GO